Genome-wide association study identifies pharmacogenomic loci linked with specific antihypertensive drug treatment and new-onset diabetes. [electronic resource]
Producer: 20181211Description: 106-112 p. digitalISSN:- 1473-1150
- Adrenergic beta-Antagonists -- therapeutic use
- Black or African American
- Aged
- Alleles
- Antihypertensive Agents -- therapeutic use
- Calcium Channel Blockers -- therapeutic use
- Diabetes Mellitus -- drug therapy
- Female
- Follow-Up Studies
- Genome-Wide Association Study -- methods
- Humans
- Hypertension -- drug therapy
- Male
- Meta-Analysis as Topic
- Middle Aged
- Odds Ratio
- Pharmacogenetics -- methods
- Polymorphism, Single Nucleotide -- genetics
- Quantitative Trait Loci -- genetics
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.